CorMedix (CRMD) EPS (Weighted Average and Diluted) (2014 - 2025)
CorMedix's (CRMD) quarterly EPS (Weighted Average and Diluted) came in at $0.07 in Q4 2025, down 70.83% year-on-year from $0.24 in Q4 2024, and down 94.44% quarter-over-quarter from $1.26 in Q3 2025.
CorMedix (CRMD) EPS (Weighted Average and Diluted) (2014 - 2025) Analysis & Trends
CorMedix has disclosed EPS (Weighted Average and Diluted) across 7 years of filings, most recently posting $0.07 for Q4 2025.
- EPS (Weighted Average and Diluted) for Q4 2025 came in at $0.07, down 70.83% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.91 (up 716.13% YoY), and the FY2025 annual result was $2.04, up 780.0% from the prior year.
- EPS (Weighted Average and Diluted) came in at $0.07 for Q4 2025 at CorMedix, down from $1.26 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.26 in Q3 2025 to a low of -$0.26 in Q4 2023.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.05 (2024), against an average of $0.04.
- Across the five-year window, EPS (Weighted Average and Diluted) sank 230.95% in 2023 and jumped 2620.0% in 2025, its largest moves.
- CorMedix's EPS (Weighted Average and Diluted) stood at -$0.26 in 2021, then increased by 20.58% to -$0.2 in 2022, then slipped by 27.56% to -$0.26 in 2023, then jumped by 192.31% to $0.24 in 2024, then plunged by 70.83% to $0.07 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at $0.07 (Q4 2025), $1.26 (Q3 2025), and $0.28 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 0.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -0.61 |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn | 0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.07 |
| Sep 30, 2025 | 1.26 |
| Jun 30, 2025 | 0.28 |
| Mar 31, 2025 | 0.30 |
| Dec 31, 2024 | 0.24 |
| Sep 30, 2024 | -0.05 |
| Jun 30, 2024 | -0.25 |
| Mar 31, 2024 | -0.25 |
| Dec 31, 2023 | -0.26 |
| Sep 30, 2023 | -0.17 |
| Jun 30, 2023 | -0.25 |
| Mar 31, 2023 | -0.24 |
| Dec 31, 2022 | -0.20 |
| Sep 30, 2022 | -0.17 |
| Jun 30, 2022 | 0.19 |
| Mar 31, 2022 | 0.18 |
| Dec 31, 2021 | -0.26 |
| Sep 30, 2021 | 0.23 |
| Jun 30, 2021 | 0.12 |
| Jun 30, 2015 | -0.13 |